Ludangshen oral liquid for treatment of convalescent COVID-19 patients: a randomized, double-blind, placebo-controlled multicenter trial

OBJECTIVE: To explore the effect of Ludangshen oral liquid for treatment of convalescent patients with coronavirus disease 2019 (COVID-19) with randomized, double-blind, placebo-controlled multicenter method. METHODS: 200 convalescent COVID-19 patients who had symptoms related to decreased digestive...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Xuedong, Peng, Bo, Huang, Xiaodong, Jiang, Hongmei, Xiong, Zhang’e, Zhang, Hong, Lian, Fengmei, Ba, Yuanming, Tong, Xiaolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976166/
https://www.ncbi.nlm.nih.gov/pubmed/35366928
http://dx.doi.org/10.1186/s13020-022-00602-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8976166/
https://www.ncbi.nlm.nih.gov/pubmed/35366928
http://dx.doi.org/10.1186/s13020-022-00602-x

Ejemplares similares